ROI in cancer research can be measured using several metrics:
1. Clinical Outcomes: Improvement in survival rates, reduction in recurrence, and enhanced quality of life. 2. Economic Impact: Reduction in treatment costs, hospital stays, and productivity loss due to illness. 3. Scientific Advancements: Number of new treatments, drugs, and technologies developed. 4. Public Health Benefits: Reduction in cancer incidence and mortality rates.
